The pharmacist market in India is extremely competitive, with the likes of Big Pharma, Aurobindo Pharma, Tata and others all competing for the lucrative niche of pet prescriptions.
The Indian pharmacist is a unique market, and one that needs to be tackled.
Pet pharmacy is the third largest market in the world after cosmetics and toothpaste, and it has been estimated that the Indian pet industry is worth about $1.6 trillion, or around Rs. 4,400 crore, annually.
There are around 4,000 pet pharmaceutical companies operating in India, with a total of 3,600 pharmacies.
In 2016, India recorded a total revenue of about Rs. 15,000 crore, and was expected to exceed $1 trillion by 2020.
However, there are concerns that pet pharma has not yet caught up with the market for drugs, which could be a major problem for the Indian pharmaceutical industry.
Here are some of the reasons why pet pharmacies are so competitive:The pet pharmacy business is relatively small, and thus, the pharmacist business can take advantage of the fact that pet supplies are relatively small.
In fact, India has about 5,000 veterinary pharmacies, while the country has about 70,000 pharmacies for drugs.
The biggest advantage of pet pharmacy over other pet pharmaceuticals is the fact there are no regulatory requirements for pet supply.
It’s also easier to run the business and run your pharmacy in the best way.
In the case of veterinary medicine, it’s a good thing because a pharmacy is where patients can get their medicines delivered.
There is also a better chance of getting proper prescriptions.
There are also other advantages to pet pharmacy: The pet pharmacist has a much higher turnover compared to the pet pharmaceutical industry, which is why it is better for the pet industry to invest in an existing pharmacy.
Pet pharmacies also tend to have a lower price tag compared to their pet pharmaceutical counterparts, and a pet pharmacy may also have a more favorable environment to operate in.
Pet pharmacies are also much cheaper than other pharmaceuticals.
Pet pharmaceuticals are typically priced between $200 and $2,000, whereas pet pharmacies can go for between $300 and $5,000.
Pet pharmacists often operate in remote areas where they can charge a premium.
Pet pharmacists can operate in areas where there are few veterinary centres, which makes it easier for them to run their pet pharmacies.
Pet pharmaceuticals can be cheaper than pet pharmacies because there are many more vets to deal with, as well as the ability to make more profit on each batch.
In India, the price of pet pharmaceutical is about half that of pet pharmacies, so the profit margins are much lower.
In addition, it is easier for the pharma companies to compete with other pet pharmas in terms of the quality of products, as the pet pharmans are typically better trained.
Pet pharmas also tend not to have the kind of stringent safety requirements that pet pharmaceutical have, which are generally found in other countries.
Pet pharmas tend to be cheaper, as there is less of a regulatory requirement for pet pharmaceutical.
Pet prescriptions tend to carry a higher cost due to the nature of the medication being prescribed.
Pet drugs are also often easier to fill than pet prescriptions, and this makes it harder for a pet pharmacy to find a vet.
Pet medication is usually more expensive than other medications.
Pet drugs are generally cheaper to fill due to having a higher patient population, as they tend to take more time.
Pet medicines are also typically easier to sell to pet pharmacies than pet medicines.
Pet medications tend to contain fewer side effects than other drugs.
Pet medications are generally less expensive to fill.
In terms of customer satisfaction, there is often an inherent feeling of superiority for pet pharmias, which can make it easier to find customers who are willing to pay a premium for their pet medicines in India.
In some cases, pet pharmacy is more profitable than other pharma brands, and there is an expectation that there will be a larger profit margin on pet medicines compared to other pet medications.
However and even if a pet pharmaceutical does manage to achieve profitability, the pet pharmacy may also struggle to compete in the long run due to its higher cost.
It is important to note that there are different levels of profit margins across the different pet pharmaceutical products, and if there is a lower profit margin, it may make it difficult for a company to survive and grow.
There also needs to always be a focus on improving customer experience, and ensuring that there is the proper quality control and safety standards.